Skip to main content

Gene Therapy Topic Center

Industry Insights
Expert Perspectives

news


News
12/13/2024
Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a revolutionary approach to treating B-cell malignancies such as CD19+ cancers. However, their application has been limited by challenges such as high costs, safety concerns with...
Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a revolutionary approach to treating B-cell malignancies such as CD19+ cancers. However, their application has been limited by challenges such as high costs, safety concerns with...
Chimeric antigen receptor T-cell...
12/13/2024
First Report Managed Care